admin

Ocumetics Director and CEO, Dean Burns, walks through relevant topics including:Successful manufacture of the Ocumetics IOLRemaining steps to first-in-human studyQ&A sessionThanks to everyone who joined us for the Webinar. It was an amazing turnout, and it was great to hear your questions and comments. We look forward to hosting more webinars in the future!https://youtu.be/U0GrNVtLNSc?si=lZYKlYUM2tH-KDjJ

Dear Shareholders, Partners, and Visionaries, I am thrilled to share a ground-breaking development from Ocumetics Technology Corp. that marks a monumental step forward in the world of vision enhancement. Today, I am pleased to announce the successful manufacture of our accommodating intraocular lens (IOL) designed to respond to the natural muscle activity of the human

Ocumetics Director and CEO, Dean Burns, walks through relevant topics including:Manufacturing of the Ocumetics IOLJourney to first-in-human studyQ&A sessionThanks to everyone who joined us for the Webinar. It was an amazing turnout, and it was great to hear your questions and comments. We look forward to hosting more webinars in the future!https://youtu.be/4zxDK3kSSYE?si=omXiuekk30ZBqHgn

Dear Ocumetics Team, Partners and Stakeholders,I am thrilled to share an exciting update in our journey to revolutionize vision correction technology. Last week, we proudly announced, in a separate press release, the commencement of manufacturing for the Ocumetics accommodating intraocular lens (IOL). This is not just a milestone for our corporation, but a significant leap

Ocumetics Announces Completion of First Tranche of Debenture Private Placement for Net Proceeds of CA$2.82 Million Dear Ocumetics Investors,  I am thrilled to share some exciting news that marks a significant milestone for our company and our mission to revolutionize eye care technology. I am pleased to announce that Ocumetics has successfully closed the first

Understanding the significance of the biocompatibility journey and why it’s essential for US FDA Approval  Earlier this week, Ocumetics sent out a press release announcing that we completed our three-month biocompatibility study and received very favorable results. Receiving favorable results in this study is a critical aspect in the field of health care and medical

Tired of glasses?  New lens technologies might offer a better way to see and experience the world.Anyone who relies on corrective eyewear has experienced its drawbacks. Maybe you are approaching your 50’s and need glasses to see up close. Maybe you left your reading glasses at home and find yourself asking for help deciphering the

Ocumetics believes its accommodating lens technology could transform the eye care industry. Dr. Garth Webb, Ocumetics’ Founder and Chief Scientific Officer, thinks nothing is as beautiful as the lens in the human eye. “It’s this gorgeous, crystal-like orb that hides just behind the pupil,” he says. But it doesn’t stay that way forever. Inevitably, as

Many of the questions we receive from investors relate to the process for obtaining US Food and Drug Administration (FDA) approval for surgical devices, such as the Ocumetics Accommodating Lens. This month’s message is focused on outlining how the process works and unpacking the steps required to obtain FDA approval. You will be thrilled to

Imagine a world in which glasses and traditional contact lenses become obsolete, and natural vision is restored with a simple and innovative solution.That's precisely what we aim to achieve with the Ocumetics Accommodating Lens technology (“Ocumetics Accommodating Lens”).